InspireMD (NSPR) Competitors $2.81 +0.02 (+0.72%) Closing price 03/12/2025 04:00 PM EasternExtended Trading$2.80 -0.02 (-0.53%) As of 03/12/2025 06:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrends NSPR vs. SMTI, AVR, ZYXI, RCEL, ELMD, LAKE, NVRO, PROF, DRTS, and INGNShould you be buying InspireMD stock or one of its competitors? The main competitors of InspireMD include Sanara MedTech (SMTI), Anteris Technologies Global (AVR), Zynex (ZYXI), AVITA Medical (RCEL), Electromed (ELMD), Lakeland Industries (LAKE), Nevro (NVRO), Profound Medical (PROF), Alpha Tau Medical (DRTS), and Inogen (INGN). These companies are all part of the "medical equipment" industry. InspireMD vs. Sanara MedTech Anteris Technologies Global Zynex AVITA Medical Electromed Lakeland Industries Nevro Profound Medical Alpha Tau Medical Inogen Sanara MedTech (NASDAQ:SMTI) and InspireMD (NYSE:NSPR) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, profitability, analyst recommendations, institutional ownership, earnings, valuation, dividends and community ranking. Do analysts rate SMTI or NSPR? Sanara MedTech presently has a consensus target price of $47.00, indicating a potential upside of 47.34%. InspireMD has a consensus target price of $4.75, indicating a potential upside of 69.04%. Given InspireMD's higher possible upside, analysts plainly believe InspireMD is more favorable than Sanara MedTech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sanara MedTech 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00InspireMD 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the MarketBeat Community believe in SMTI or NSPR? Sanara MedTech received 17 more outperform votes than InspireMD when rated by MarketBeat users. Likewise, 58.33% of users gave Sanara MedTech an outperform vote while only 4.30% of users gave InspireMD an outperform vote. CompanyUnderperformOutperformSanara MedTechOutperform Votes2158.33% Underperform Votes1541.67% InspireMDOutperform Votes44.30%Underperform Votes8995.70% Which has more risk and volatility, SMTI or NSPR? Sanara MedTech has a beta of 1.37, meaning that its stock price is 37% more volatile than the S&P 500. Comparatively, InspireMD has a beta of 0.88, meaning that its stock price is 12% less volatile than the S&P 500. Does the media prefer SMTI or NSPR? In the previous week, InspireMD had 6 more articles in the media than Sanara MedTech. MarketBeat recorded 8 mentions for InspireMD and 2 mentions for Sanara MedTech. Sanara MedTech's average media sentiment score of 0.94 beat InspireMD's score of -0.14 indicating that Sanara MedTech is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sanara MedTech 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive InspireMD 0 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Is SMTI or NSPR more profitable? Sanara MedTech has a net margin of -10.71% compared to InspireMD's net margin of -413.96%. Sanara MedTech's return on equity of -19.86% beat InspireMD's return on equity.Company Net Margins Return on Equity Return on Assets Sanara MedTech-10.71% -19.86% -10.91% InspireMD -413.96%-69.42%-57.68% Which has preferable valuation & earnings, SMTI or NSPR? Sanara MedTech has higher revenue and earnings than InspireMD. Sanara MedTech is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSanara MedTech$78.06M3.57-$4.30M-$0.99-32.22InspireMD$6.82M10.75-$19.92M-$0.75-3.75 Do institutionals and insiders hold more shares of SMTI or NSPR? 8.1% of Sanara MedTech shares are owned by institutional investors. Comparatively, 44.8% of InspireMD shares are owned by institutional investors. 54.1% of Sanara MedTech shares are owned by company insiders. Comparatively, 29.7% of InspireMD shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. SummarySanara MedTech beats InspireMD on 10 of the 16 factors compared between the two stocks. Remove Ads Get InspireMD News Delivered to You Automatically Sign up to receive the latest news and ratings for NSPR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NSPR vs. The Competition Export to ExcelMetricInspireMDSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$73.30M$4.31B$5.64B$19.16BDividend YieldN/A39.84%4.89%3.78%P/E Ratio-3.7528.1623.7332.82Price / Sales10.7550.26381.7527.73Price / CashN/A51.0838.0517.55Price / Book1.546.086.904.52Net Income-$19.92M$67.09M$3.18B$1.02B7 Day Performance-3.10%-0.64%6.23%-2.60%1 Month PerformanceN/A-9.16%1.18%-5.32%1 Year Performance14.23%18.91%12.45%3.62% InspireMD Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NSPRInspireMD2.0543 of 5 stars$2.81+0.7%$4.75+69.0%+14.2%$73.30M$6.82M-3.7550Analyst ForecastNews CoverageGap UpHigh Trading VolumeSMTISanara MedTech2.5552 of 5 stars$32.82-5.4%$47.00+43.2%-13.4%$286.88M$78.06M-33.1560News CoverageAVRAnteris Technologies GlobalN/A$7.21+3.0%$16.50+128.8%N/A$259.13M$2.71M0.00138News CoverageZYXIZynex3.3084 of 5 stars$7.21flat$14.00+94.2%-72.9%$229.61M$193.67M48.071,100Earnings ReportAnalyst ForecastNews CoverageGap DownRCELAVITA Medical2.6609 of 5 stars$8.73-4.1%$17.25+97.6%-47.2%$228.88M$64.25M-3.65130ELMDElectromed1.0112 of 5 stars$26.18-3.2%$38.00+45.1%+46.5%$224.02M$59.63M34.91160Analyst DowngradeBuyback AnnouncementNews CoverageLAKELakeland Industries4.8771 of 5 stars$23.13-2.0%$27.50+18.9%+34.1%$219.71M$151.82M-257.001,750Analyst ForecastShort Interest ↓News CoveragePositive NewsNVRONevro1.4117 of 5 stars$5.74+0.3%$6.43+12.0%-60.6%$214.90M$419.15M-3.031,215PROFProfound Medical2.2678 of 5 stars$6.99+0.9%$14.25+103.9%-13.3%$209.98M$8.98M-5.22150Earnings ReportShort Interest ↑DRTSAlpha Tau Medical2.4788 of 5 stars$2.91-3.6%$8.00+174.9%-8.3%$203.48MN/A-6.7780Earnings ReportNews CoverageINGNInogen3.0701 of 5 stars$8.13-2.4%$7.00-13.9%+12.9%$193.64M$335.71M-3.611,030 Remove Ads Related Companies and Tools Related Companies SMTI Competitors AVR Competitors ZYXI Competitors RCEL Competitors ELMD Competitors LAKE Competitors NVRO Competitors PROF Competitors DRTS Competitors INGN Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:NSPR) was last updated on 3/13/2025 by MarketBeat.com Staff From Our PartnersElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InspireMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share InspireMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
